Sign In
Buy AGIO
$27.68
+1.17 (+4.41%)
At Close: Jun 03, 2026
Why Agios Pharmaceuticals Stock Is Up More Than 21% Today
12:08pm, Tuesday, 31'st Mar 2026
Agios Pharmaceuticals' mitapivat has shown tremendous promise as a treatment for sickle cell disease. It's been so promising, in fact, that the U.S. Food and Drug Administration is allowing the compan
Insider Sells AGIO Shares Worth $82,000 -- But Context Is Everything
12:03pm, Tuesday, 31'st Mar 2026
2,959 shares sold for a total of ~$82,000 at a weighted average price of around $27.80 per share on March 5, 2026. The transaction represented 36.5% of Krishnan's direct common stock holdings, reducin
AGIO ALERT- The Gross Law Firm Has Commenced an Investigation on Behalf of Agios Pharmaceuticals, Inc. Shareholders Who Lost Money
09:00am, Tuesday, 31'st Mar 2026
NEW YORK, March 31, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Agios Pharmaceuticals, Inc.: Due to the forgoing, The Gross Law Firm is investigating potenti
PK Activation Gains Momentum in Thalassemia Agios' Aqvesme Launch Reflects Strong Promise with Deliberate Uptake
08:45am, Tuesday, 31'st Mar 2026
With physicians identifying up to one-third of patients as candidates, early adoption reflects strong enthusiasm tempered by cautious real-world uptake. With physicians identifying up to one-third of
Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA
07:00am, Tuesday, 31'st Mar 2026
Company has already submitted proposed confirmatory trial for FDA review, as required under accelerated approval pathway Company plans to submit mitapivat sNDA in sickle cell disease in the coming m
Agios Pharmaceuticals, Inc. $AGIO Stock Holdings Increased by Assenagon Asset Management S.A.
03:32am, Tuesday, 31'st Mar 2026
Assenagon Asset Management S.A. boosted its holdings in shares of Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) by 64.5% in the undefined quarter, according to the company in its most recent disclosure w
AGIO STOCK ALERT: Levi & Korsinsky Notifies Agios Pharmaceuticals, Inc. Investors of an Ongoing Investigation
09:00am, Wednesday, 25'th Mar 2026
NEW YORK, March 25, 2026 /PRNewswire/ -- Levi & Korsinsky notifies investors that it has commenced an investigation of Agios Pharmaceuticals, Inc. ("Agios Pharmaceuticals, Inc.") (NASDAQ: AGIO) concer
Agios Pharmaceuticals Stock Declines 23% in 6 Months: Here's Why
10:46am, Wednesday, 18'th Mar 2026
AGIO sinks 23% as mixed phase III data for mitapivat in SCD and an FDA review delay for thalassemia dent investors' confidence in its key growth drug.
NEW YORK, March 18, 2026 /PRNewswire/ -- Levi & Korsinsky notifies investors that it has commenced an investigation of Agios Pharmaceuticals, Inc. ("Agios Pharmaceuticals, Inc.") (NASDAQ: AGIO) concer
Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? Contact The Gross Law Firm Regarding an Ongoing Investigation
09:00am, Tuesday, 17'th Mar 2026
NEW YORK, March 17, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Agios Pharmaceuticals, Inc.: Due to the forgoing, The Gross Law Firm is investigating potenti
ArrowMark Colorado Holdings LLC Has $27.29 Million Holdings in Agios Pharmaceuticals, Inc. $AGIO
04:24am, Sunday, 15'th Mar 2026
ArrowMark Colorado Holdings LLC increased its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) by 3.2% during the third quarter, according to the company in its most recent filing with th
Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
09:00am, Wednesday, 11'th Mar 2026
NEW YORK, March 11, 2026 /PRNewswire/ -- Levi & Korsinsky notifies investors that it has commenced an investigation of Agios Pharmaceuticals, Inc. ("Agios Pharmaceuticals, Inc.") (NASDAQ: AGIO) concer
NEW YORK, March 10, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Agios Pharmaceuticals, Inc.: Due to the forgoing, The Gross Law Firm is investigating potenti
NEW YORK, March 4, 2026 /PRNewswire/ -- Levi & Korsinsky notifies investors that it has commenced an investigation of Agios Pharmaceuticals, Inc. ("Agios Pharmaceuticals, Inc.") (NASDAQ: AGIO) concer
NEW YORK, March 3, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Agios Pharmaceuticals, Inc.: Due to the forgoing, The Gross Law Firm is investigating potentia
